[
  {
    "ts": "2025-07-15T17:37:00+00:00",
    "headline": "Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management",
    "summary": "DURHAM, N.C., July 15, 2025--Sightview, the only EHR and practice management partner focused solely on eyecare, has appointed Melissa Wright and Casi Nestelroad as VPs.",
    "url": "https://finance.yahoo.com/news/sightview-expands-leadership-bench-appointing-131500350.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "27e623d1-8927-3387-87df-8acaf628bfaf",
      "content": {
        "id": "27e623d1-8927-3387-87df-8acaf628bfaf",
        "contentType": "STORY",
        "title": "Sightview Expands Leadership Bench, Appointing Vice Presidents of Client Operations and Product Management",
        "description": "",
        "summary": "DURHAM, N.C., July 15, 2025--Sightview, the only EHR and practice management partner focused solely on eyecare, has appointed Melissa Wright and Casi Nestelroad as VPs.",
        "pubDate": "2025-07-15T17:37:00Z",
        "displayTime": "2025-07-15T17:37:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/7386a8f28ddba03417176bf442e62de8",
          "originalWidth": 816,
          "originalHeight": 260,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/T.Lz3cGgIWEeF1GORmSrhA--~B/aD0yNjA7dz04MTY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7386a8f28ddba03417176bf442e62de8.cf.webp",
              "width": 816,
              "height": 260,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5kp1Z6odW8oTWmGqpyl6pw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/7386a8f28ddba03417176bf442e62de8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/sightview-expands-leadership-bench-appointing-131500350.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/sightview-expands-leadership-bench-appointing-131500350.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T17:25:55+00:00",
    "headline": "Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion",
    "summary": "Cencora (COR) recently executed a distribution services agreement with Citius Oncology, signaling an expansion in its pharmaceutical distribution capabilities. Over the past quarter, Cencora’s share price rose by 4.4%, aligning with the market trend of major indexes reaching record highs. This gain is supported by several corporate actions, including strong second-quarter earnings and ongoing share buybacks, which may have bolstered investor confidence. The dividend announcement and...",
    "url": "https://finance.yahoo.com/news/cencora-cor-partners-citius-oncology-172555060.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "b8994160-bf9e-391b-b79a-8744ef686c8d",
      "content": {
        "id": "b8994160-bf9e-391b-b79a-8744ef686c8d",
        "contentType": "STORY",
        "title": "Cencora (COR) Partners With Citius Oncology For Immunotherapy Distribution Expansion",
        "description": "",
        "summary": "Cencora (COR) recently executed a distribution services agreement with Citius Oncology, signaling an expansion in its pharmaceutical distribution capabilities. Over the past quarter, Cencora’s share price rose by 4.4%, aligning with the market trend of major indexes reaching record highs. This gain is supported by several corporate actions, including strong second-quarter earnings and ongoing share buybacks, which may have bolstered investor confidence. The dividend announcement and...",
        "pubDate": "2025-07-15T17:25:55Z",
        "displayTime": "2025-07-15T17:25:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RRNXgyMUSlb_eEze_cgq5g--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/RHMU_mlJxbIr8zuj1RZ3Hw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/0d420881cf99e8229dddbfddf7bc7ebf.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/cencora-cor-partners-citius-oncology-172555060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/cencora-cor-partners-citius-oncology-172555060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            },
            {
              "symbol": "CTOR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T13:12:00+00:00",
    "headline": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
    "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
    "url": "https://finance.yahoo.com/news/bd-partners-waters-build-high-131200851.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5cff4155-238a-3596-9c39-59083c45db6e",
      "content": {
        "id": "5cff4155-238a-3596-9c39-59083c45db6e",
        "contentType": "STORY",
        "title": "BD Partners With Waters to Build High-Volume Diagnostics Leader",
        "description": "",
        "summary": "BDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.",
        "pubDate": "2025-07-15T13:12:00Z",
        "displayTime": "2025-07-15T13:12:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uKAK5RzbQ_vsUIbORK8gvQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0coGOoYQ8rONNrj5AqJ8kw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-partners-waters-build-high-131200851.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-partners-waters-build-high-131200851.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WAT"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-15T13:02:00+00:00",
    "headline": "Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?",
    "summary": "BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.",
    "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-130200568.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a6fcd526-f38b-3acc-af43-4089bacb034c",
      "content": {
        "id": "a6fcd526-f38b-3acc-af43-4089bacb034c",
        "contentType": "STORY",
        "title": "Will Robust MedSurg Performance Fuel Boston Scientific's Q2 Earnings?",
        "description": "",
        "summary": "BSX eyes strong Q2 with MedSurg momentum, solid Cardiovascular growth and benefits from key tech acquisitions.",
        "pubDate": "2025-07-15T13:02:00Z",
        "displayTime": "2025-07-15T13:02:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/0b6a08d393cca3baa61f90de397839c4",
          "originalWidth": 620,
          "originalHeight": 413,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rh9k907wwkdNsQxjGuyhOg--~B/aD00MTM7dz02MjA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0b6a08d393cca3baa61f90de397839c4.cf.webp",
              "width": 620,
              "height": 413,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SL.HApql4gLGKFBrPDDxwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/0b6a08d393cca3baa61f90de397839c4.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-130200568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/robust-medsurg-performance-fuel-boston-130200568.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "COR"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]